A Phase II Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
收藏DataCite Commons2025-07-24 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003183/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Purpose of the study is to test whether adalimumab can induce clinical remission in subjects with active Crohn's disease when compared to placebo (an inactive substance)
提供机构：
Vivli
创建时间：
2018-10-27
